Full Press Release Details
Auna Signs Exclusive
Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey
March, 07, 2025 - Auna S.A. (NYSE: AUNA) ("Auna" or the "Company"), a Latin American healthcare
company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician
group practicing at Organizaci n Para Cuidado Integral en Oncolog a, S.A. de C.V. known as Opci n Oncolog a,
the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading
oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico.
agreement, eight highly regarded physicians - six oncologists and two radiation oncologists - will join Auna. Today, their
practice manages approximately 30% of all private oncology treatments in Monterrey, referring patients to multiple facilities across
the city. Through this partnership, Auna will integrate 100% of these treatments within its network over time, strengthening care coordination
and enhancing the patient experience.
The team will relocate
to Doctors Hospital, further strengthening Auna's oncology capabilities. This move will position Auna's Oncology Center as
one of the few multidisciplinary and fully integrated oncology centers operating in Mexico's private healthcare market. Among the
distinguished doctors joining Auna are Dr. C sar Gonz lez de Le n and Dr. Cuauht moc De la Pe a Hinojosa,
both recognized as leading oncologists in Mexico and widely referenced in their field. Dr. Gonz lez will play a key leadership
role on Auna's Oncology Board, serving as Chair of Medical Oncology and Co-Chair of the practice for Auna's Center of Excellence
in Oncology in Mexico. Dr. De la Pe a Hinojosa will lead Radiation Oncology as Chair of Radiation Oncology on Auna Mexico's
strengthens Auna's ongoing expansion and Auna's commitment to delivering world-class oncology care. It follows the successful
launch of OncoMexico last year and aligns with the upcoming inauguration of Auna's Oncology Research Center in Mexico. This new
research facility will collaborate with Auna's existing research centers in Peru and Colombia, driving clinical research and advancing
cancer treatment throughout the region.
is an important step for Auna in Mexico to continue implementing the AunaWay," said Suso Zamora, Executive Chairman and President
of Auna. "By bringing together some of the country's most respected oncology experts and consolidating our oncology services,
we are reinforcing our mission to provide the highest quality cancer care. With this partnership, Auna is poised to become the leading
oncology provider in Monterrey."
de Le n and Dr. De la Pe a Hinojosa added, "We are thrilled as a team to join Auna's mission to elevate oncology
care in Mexico. This collaboration allows us to enhance patient care, drive research, and set new standards in oncology treatment by
partnering with the best in the industry."
is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia,
focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering
in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America s largest modern
healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio
of oncological plans and selected general healthcare plans. As of September 30, 2024, Auna's network included 31 healthcare network
facilities, including hospitals, outpatient, prevention and wellness facilities with 2,308 beds, and 1.3 million healthcare plans.
press release contains forward-looking statements. Forward-looking statements convey our current expectations or forecasts of future
events. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance
or achievements to differ materially from the forward-looking statements that we make. Forward-looking statements typically are identified
by words or phrases such as "may," "will," "expect," "anticipate," "aim,"
"estimate," "intend," "project," "plan," "believe," "potential,"
"continue," "is/are likely to," or other similar expressions. Forward-looking statements that appear in a number
of places in this press release include, but are not limited to, statements regarding the intent, belief or current expectations, regarding
various matters, including, the expected impact of our agreement with a physician group practicing at Opci n Oncolog a
and our integration of their practice into Auna. Any or all of our forward-looking statements in this press release may turn out to be
inaccurate. Our actual results could differ materially from those contained in forward-looking statements due to a number of factors.
forward-looking statements in this press release represent our expectations and forecasts as of the date of this press release. Except
as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, after the date of this press release. For a discussion of the risks facing the Company which
could affect whether these forward-looking statements are realized, see our Form F-1 filing with the U.S. Securities and Exchange Commission.
more information visit www.aunainvestors.com
Investor Relations Contact